| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 |
Director
Trans History: 13
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,775 | -- | 2,775 |
| Jun 11, 2025 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,775 | -- | 2,775 |
| Jun 11, 2025 |
Director
Trans History: 6
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,775 | -- | 2,775 |
| Jun 11, 2025 |
Director
Trans History: 17
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,775 | -- | 2,775 |
| Jun 11, 2025 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,775 | -- | 2,775 |
| Jun 03, 2025 |
Principal Accounting Officer
Trans History: 15
|
Principal Accounting Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 7 | $3.69 | 263 |
| Jun 03, 2025 |
Chief Medical Officer
Trans History: 21
|
Chief Medical Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 24 | $3.69 | 713 |
| Jun 03, 2025 |
General Counsel
Trans History: 11
|
General Counsel | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 25 | $3.69 | 269 |
| Jun 03, 2025 |
Director, President and CEO
Trans History: 41
|
Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 75 | $3.69 | 1,708 |
| Jun 03, 2025 |
Director, President and CEO
Trans History: 41
|
Director, President and CEO | Form 4 | Other acquisition or disposition | -- | -- | 8 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.